Via rescue experiments, we have further proved that suppressing miR-125b-5p or increasing E2F3 expression levels sufficiently recovered POU6F2-AS2 depletion–induced anticarcinostatic activities in NSCLC. This evidence concerns the gene E2F3 and non-small cell lung carcinoma.